Showing results (1-10 of 14,322) with videos related to
Sort By:
Pageof 1,433
Current Cancer Drug Targets|May 17, 2007
MUC1 is a promising therapeutic target for prostate cancer therapyY Li, P J CozziThe Australian and New Zealand Journal of Surgery|August 12, 1999
A fellowship in the USA: essential information for the Australasian medical graduateP J CozziCurrent Cancer Drug Targets|April 8, 2010
CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancerJ L Hao, P J Cozzi, A Khatri, et al.HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|January 1, 1996
Two cases of spontaneous liver rupture and literature reviewP J Cozzi, D L MorrisChest|November 13, 1999
Cyclophosphamide in the treatment of pulmonary diseases: survey of use, training, and practitioner knowledge baseP J Cozzi, J B HallCell Death & Disease|October 26, 2013
Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistanceL Chang, P H Graham, J Hao, et al.Cell Death & Disease|October 3, 2014
PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathwaysL Chang, P H Graham, J Hao, et al.Cancer|August 1, 1995
Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumorsP J Cozzi, R Englund, D L MorrisCritical Care Medicine|September 1, 1995
Pulmonary artery diastolic-occlusion pressure gradient is increased in acute pulmonary embolismP J Cozzi, J B Hall, G A SchmidtPageof 1,433